CD274 and hyperinsulinemic hypoglycemia, familial, 4: In a case report of a PD-L1-negative patient showing a partial response to durvalumab, the effectiveness of immunotherapy was thought to be related to the underlying mismatch repair (MMR) deficiency [14].